Overview
- Rocket Lab entered an equity distribution agreement that allows it to sell up to $1 billion of common stock over time to fund growth initiatives, potential acquisitions, and general corporate purposes.
- Shares jumped 10.2% Tuesday to $78.59 on news of two upcoming Electron missions, then fell about 5% after-hours, with premarket trading Wednesday down roughly 3.7% to $75.70.
- Rocket Lab said ESA’s two Pathfinder A satellites are integrated and encapsulated for the 85th Electron mission, “Daughter of the Stars,” its first dedicated launch for the agency from Launch Complex 1 in New Zealand no later than March 24.
- The 84th Electron mission, “Eight Days A Week,” will deploy Synspective’s eighth StriX SAR satellite within a window that begins March 19, following seven completed Synspective launches and with about 20 more planned.
- The company reported approximately $828.66 million in cash at year-end 2025, while analysts maintain a broadly positive stance with an average target near $75.92 and a $120 target from Bank of America, alongside recent insider sales of about $139 million and institutional ownership near 71.8%.